Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
trastuzumab deruxtecan
×
Thoracic
×
Clear all
Filters
3
NCT03505710
2025-05-30
DESTINY-Lung01
Daiichi Sankyo
Phase 2
Terminated
181 enrolled
17 charts
1 FDA